OVERSEA CHINESE BANKING Corp Ltd Buys 6,252 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

OVERSEA CHINESE BANKING Corp Ltd raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1,151.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,795 shares of the medical equipment provider's stock after buying an additional 6,252 shares during the period. OVERSEA CHINESE BANKING Corp Ltd's holdings in Intuitive Surgical were worth $3,365,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Castleark Management LLC grew its stake in shares of Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after purchasing an additional 2,990 shares during the last quarter. Arlington Trust Co LLC grew its stake in shares of Intuitive Surgical by 34.5% in the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock worth $369,000 after purchasing an additional 191 shares during the last quarter. Aaron Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock worth $1,243,000 after buying an additional 78 shares during the period. Ewing Morris & Co. Investment Partners Ltd. acquired a new position in shares of Intuitive Surgical in the fourth quarter worth about $454,000. Finally, Whalerock Point Partners LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter worth about $209,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director owned 6,371 shares of the company's stock, valued at $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president directly owned 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock valued at $2,611,577 over the last three months. 0.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have commented on ISRG. Barclays decreased their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Piper Sandler decreased their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Royal Bank Of Canada decreased their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their target price for the stock from $515.00 to $440.00 in a report on Monday, June 9th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $592.86.

Intuitive Surgical Trading Up 0.1%

NASDAQ ISRG traded up $0.41 during trading on Wednesday, reaching $512.64. The company's stock had a trading volume of 1,863,510 shares, compared to its average volume of 1,685,801. The stock has a market capitalization of $183.74 billion, a PE ratio of 75.17, a PEG ratio of 5.43 and a beta of 1.64. The business has a 50-day moving average price of $536.71 and a 200-day moving average price of $536.21. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the previous year, the company earned $1.50 earnings per share. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.